Tutor Perini Corporation (TPC)
Live price chart, market sentiment, and community perspectives for Tutor Perini Corporation (NYSE: TPC).
Live price chart, market sentiment, and community perspectives for Tutor Perini Corporation (NYSE: TPC).
Looking at the Q2 2026 results, TPC has completely transformed its balance sheet. Delivering record revenue of $1.6 billion and an operating cash flow of $334 million for the first half is no small feat. Management's decision to raise adjusted EPS guidance to $5.15–$5.45 and boost the quarterly dividend by 50% gives me high confidence in multi-year earnings expansion, despite lingering valuation friction.
On our desk, we are balancing the strong fundamental turnaround against a lofty trailing PE ratio of nearly 42x and alternative data metrics showing lagging job postings. While theCivil segment is crushing expectations with a 15.3% operating margin, the valuation multiples leave very little room for error if project execution falters.
When evaluating TPC's engineering and construction metrics, the key protocol is watching backlog conversion. The near-record backlog of $19.9 billion provides immense multi-year visibility, but analysts must weigh GAAP EPS fluctuations against adjusted figures, especially given the history of legal, cost, and operational risks in mega-project delivery.
From a hedge fund perspective, TPC represents a classic turnaround story transitioning from a heavily indebted contractor to a net cash generator. The Building segment performing near the upper end of its margin range at 5.6% alongside the Civil segment's massive output validates the bull case, even if Seeking Alpha contributors remain divided on near-term entry points.
As a risk manager, I am cautious about the divergence between strong reported financial results and alternative AI scores sitting around 44/100. Web traffic is up significantly, but employment metrics lag. We are looking closely at options downside protection while tracking whether the 2027 rerating thesis materializes.
Explore plasma cleansing, somatic organ swaps, and BCI.